SCYNEXIS
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.About SCYX
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
SCYX Key Statistics
Stock Snapshot
With a market cap of 38.31M, SCYNEXIS(SCYX) trades at $3.85. The stock has a price-to-earnings ratio of -2.07.
During the trading session on 2026-10-27, SCYNEXIS(SCYX) shares reached a daily high of $3.90 and a low of $3.66. At a current price of $3.85, the stock is +5.2% higher than the low and still -1.3% under the high.
Trading volume for SCYNEXIS(SCYX) stock has reached 21.67K, versus its average volume of 72.98K.
Over the past 52 weeks, SCYNEXIS(SCYX) stock has traded between a high of $9.12 and a low of $3.53.
Over the past 52 weeks, SCYNEXIS(SCYX) stock has traded between a high of $9.12 and a low of $3.53.
SCYX News
Scynexis (SCYX) announced topline results from its Phase 1 single ascending dose, or SAD, and multiple ascending dose, or MAD, trial of the intravenous, or IV,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.